OWI can report regulatory compliant information back to the manufacturer concerning real-world experiences (RWE) and safety information in a real-world setting outside the United States. This information can guide future promotional activities and help identify physician/prescriber characteristics, preferences, and early clinical practices and perceptions that can reveal actual prescribing behavior.
In addition, RWE can:
- be useful in economic and budgetary evaluations
- establish evidence for a novel agent use in a specific indication
- support development of physician educational and patient support materials
- identify compliance issues in specific patient groups